英文名稱 |
中文名稱 |
CAS號(hào) |
操作 |
E3 ligase Ligand 14 |
((S)-1-(((S)-1-環(huán)己基-2-((2S,4S)-4-(3-羥基苯氧基)-2-(((R)-1,2,3,4-四氫萘-1-基)氨基甲?;?吡咯烷-1-基)-2-氧代乙基)氨基)-1-氧代丙烷-2-基)(甲基)氨基甲酸叔丁酯 |
2241489-43-8 |
詳細(xì)
|
2-(2,6-dioxo-3-piperidinyl)-5-[4-[2-(2-hydroxyethoxy)ethyl]-1-piperazinyl]-1H-Isoindole-1,3(2H)-dione, |
|
2467424-27-5 |
詳細(xì)
|
Pentanoic acid, 5-[[2-(2,6-dioxo-3-piperidinyl)- 2,3-dihydro-1,3-dioxo-1H-isoindol-5-yl]amino]- |
沙利度胺-5-氨基-戊酸 |
2412056-33-6 |
詳細(xì)
|
Bestatin hydrochloride |
氨肽酶 |
65391-42-6 |
詳細(xì)
|
Pomalidomide-amido-C1-Br |
2-溴-N-(2-(2,6-二氧代哌啶-3-基)-1,3-二氧代異吲哚啉-4-基)乙酰胺 |
2351106-38-0 |
詳細(xì)
|
E3 ligase Ligand 10 |
(S)-2-((S)-1-((S)-2-((S)-2-((((9H-芴-9-基)甲氧基)羰基)(甲基)氨基)丙酰胺基)-2-環(huán)己基乙酰基)吡咯烷-2-甲酰胺基)-3,3-二苯基丙酸 |
1073560-68-5 |
詳細(xì)
|
VHL Ligand-Linker Conjugates 15 |
|
2375564-62-6 |
詳細(xì)
|
(S,R,S)-AHPC-PEG2-acid |
3-(2-(3-(((S)-1-((2S,4R)-4-羥基-2-((4-(4-甲基噻唑-5-基)芐基)氨基甲?;?吡咯烷-1-基)-3,3-二甲基-1-氧代丁烷-2-基)氨基)-3-氧代丙氧基)乙氧基)丙酸 |
2172820-09-4 |
詳細(xì)
|
Lenalidomide-PEG1-azide |
化合物 LENALIDOMIDE-PEG1-AZIDE |
2185795-67-7 |
詳細(xì)
|
cIAP1 Ligand-Linker Conjugates 3 |
|
2222354-20-1 |
詳細(xì)
|
Pomalidomide-PEG4-azide |
泊馬度胺-NH-四聚乙二醇-疊氮 |
2271036-47-4 |
詳細(xì)
|
5-[[2-[2-(2-aminoethoxy)ethoxy]ethyl]amino]-2-(2,6-dioxo-3-piperidinyl)-1H-Isoindole-1,3(2H)-dione, |
沙利度胺-5-氨基-二聚乙二醇-乙胺 |
2064175-30-8 |
詳細(xì)
|
5-[(6-aminobutyl)amino]-2-(2,6-dioxo-3-piperidinyl)-1H-Isoindole-1,3(2H)-dione, 2,2,2-trifluoroacetate |
|
2097509-17-4 |
詳細(xì)
|
Pomalidomide-C2-amido-(C1-O-C5-O-C1)2-COOH |
E3 LIGASE LIGAND-LINKER CONJUGATES 49|||CEREBLON LIGAND-LINKER CONJUGATES 14 |
2351103-63-2 |
詳細(xì)
|
(4R,5S)-nutlin carboxylic acid |
2-(4-((4R,5S)-4,5-雙(4-氯苯基)-2-(2-異丙氧基-4-甲氧基苯基)-4,5-二氫-1H-咪唑-1-羰基)-2-氧代哌嗪-1-基)乙酸 |
2306390-08-7 |
詳細(xì)
|
Bestatin-amido-Me |
貝斯汀-酰胺-ME |
339186-54-8 |
詳細(xì)
|
1H-Isoindole-1,3(2H)-dione, 5-[[2-[2-(2-aminoethoxy)ethoxy]ethyl]amino]-2-(2,6-dioxo-3-piperidinyl)-, 2,2,2-trifluoroacetate (1:) |
|
2648285-33-8 |
詳細(xì)
|
cIAP1 ligand 1 |
((S)-1-(((S)-1-環(huán)己基-2-((S)-2-(4-(3-羥基苯甲?;?噻唑-2-基)吡咯烷-1-基)-2-氧代乙基)氨基)-1-氧代丙烷-2-基)(甲基)氨基甲酸叔丁酯 |
2095244-42-9 |
詳細(xì)
|
MV-1 |
MV1 |
1001600-54-9 |
詳細(xì)
|
5-[(4-aminobutyl)amino]-2-(2,6-dioxo-3-piperidinyl)-1H-Isoindole-1,3(2H)-dione, |
沙利度胺-5-氨基-丁胺 |
1957236-35-9 |
詳細(xì)
|
Thalidomide-O-PEG4-amine |
沙利度胺-O-四聚乙二醇-氨基 |
2401832-00-4 |
詳細(xì)
|
2-(2,6-dioxo-3-piperidinyl)-5-[[2-(2-hydroxyethoxy)ethyl]amino]-1H-Isoindole-1,3(2H)-dione, |
|
2357113-24-5 |
詳細(xì)
|
5-[(6-aminobutyl)amino]-2-(2,6-dioxo-3-piperidinyl)-1H-Isoindole-1,3(2H)-dione, |
沙利度胺-5-氨基-己胺 |
2097509-16-3 |
詳細(xì)
|
5-[4-[2-[2-[2-(2-aminoethoxy)ethoxy]ethoxy]ethyl]-1-piperazinyl]-2-(2,6-dioxo-3-piperidinyl)-1H-Isoindole-1,3(2H)-dione, |
|
2357113-68-7 |
詳細(xì)
|
Thalidomide-O-PEG4-NHS ester |
薩力多胺-O-四聚乙二醇-NHS 酯 |
2411681-88-2 |
詳細(xì)
|
cIAP1 Ligand-Linker Conjugates 1 |
|
2357114-75-9 |
詳細(xì)
|
Cereblon modulator 1 |
2-(4-氯苯基)-N-((2-(2,6-二氟哌啶-3-基)-1-氧代異吲哚啉-5-基)甲基)-2,2-二氟乙酰胺 |
1860875-51-9 |
詳細(xì)
|
Biotin-PEG6-Thalidomide |
生物素-六聚乙二醇-沙利度胺 |
2144775-48-2 |
詳細(xì)
|
Pomalidomide |
泊馬度胺 |
19171-19-8 |
詳細(xì)
|
5-[[2-[2-(2-aminoethoxy)ethoxy]ethyl]amino]-2-(2,6-dioxo-3-piperidinyl)-1H-Isoindole-1,3(2H)-dione, 2,2,2-trifluoroacetate |
|
2412056-18-7 |
詳細(xì)
|
5-[(8-aminobutyl)amino]-2-(2,6-dioxo-3-piperidinyl)-1H-Isoindole-1,3(2H)-dione, |
沙利度胺-5-氨基-辛胺 |
2097509-48-1 |
詳細(xì)
|
VH032 thiol |
VH032thiol |
2098836-54-3 |
詳細(xì)
|
5-[(7-aminobutyl)amino]-2-(2,6-dioxo-3-piperidinyl)-1H-Isoindole-1,3(2H)-dione, |
沙利度胺-5-氨基-庚胺 |
2412056-40-5 |
詳細(xì)
|
5-[(5-aminobutyl)amino]-2-(2,6-dioxo-3-piperidinyl)-1H-Isoindole-1,3(2H)-dione, |
沙利度胺-5-氨基-戊胺 |
2307476-95-3 |
詳細(xì)
|
Thalidomide-O-PEG4-Boc |
薩力多胺-O-四聚乙二醇-叔丁酯 |
2411681-87-1 |
詳細(xì)
|
Thalidomide-O-amido-PEG4-azide |
沙利度胺-O-酰胺-四聚乙二醇-疊氮 |
2411681-89-3 |
詳細(xì)
|
Iberdomide |
(S)-3-(4-((4-(嗎啉甲基)芐基)氧基)-1-氧代異吲哚-2-基)哌啶-2,6-二酮 |
1323403-33-3 |
詳細(xì)
|
BC-1215 |
N1,N2-雙(4-(吡啶-2-基)芐基)乙烷-1,2-二胺 |
1507370-20-8 |
詳細(xì)
|
Nutlin-3a |
4-[[(4S,5R)-4,5-雙(4-氯苯基)-4,5-二氫-2-[4-甲氧基-2-(1-甲基乙氧基)苯基]-1H-咪唑-1-YL]羰基]-2-哌嗪酮 |
675576-98-4 |
詳細(xì)
|
1H-Isoindole-1,3(2H)-dione, 5-[[2-[2-(2-aminoethoxy)ethoxy]ethyl]amino]-2-(2,6-dioxo-3-piperidinyl)-, hydrochloride (1:1) |
|
2357110-58-6 |
詳細(xì)
|
MV-1-NH-Me |
(S)-1-((S)-2-環(huán)己基-2-((S)-2-(甲基氨基)丙酰胺基)乙?;?-N-((S)-1-(甲基氨基)-1-氧代-3,3-二苯基丙烷-2-基)吡咯烷-2-甲酰胺 |
2095244-62-3 |
詳細(xì)
|
cIAP1 ligand 2 |
((S)-1-(((S)-1-環(huán)己基-2-((S)-2-(4-(3-羥基苯甲?;?噻唑-2-基)吡咯烷-1-基)-2-氧代乙基)氨基)-1-氧代丙烷-2-基)(甲基)氨基甲酸芐酯 |
2357114-70-4 |
詳細(xì)
|
TD-106 |
3-(5-氨基-4-氧代苯并[D][1,2,3]三嗪-3(4H)-基)哌啶-2,6-二酮 |
2250288-69-6 |
詳細(xì)
|
5-[(3-aminopropyl)amino]-2-(2,6-dioxo-3-piperidinyl)-1H-Isoindole-1,3(2H)-dione, |
沙利度胺-5-氨基-丙胺 |
2412056-37-0 |
詳細(xì)
|
5-[(2-aminoethyl)amino]-2-(2,6-dioxo-3-piperidinyl)-1H-Isoindole-1,3(2H)-dione, |
沙利度胺-5-氨基-乙胺 |
2307476-92-0 |
詳細(xì)
|
E3 ligase Ligand 18 |
E3 連接酶配體 18 |
2241669-88-3 |
詳細(xì)
|
VL285 |
(2S,4R)-4-羥基-1-((S)-3-甲基-2-(1-氧代異吲哚啉-2-基)丁酰基)-N-(4-(4-甲基噻唑-5-基)芐基)吡咯烷-2-甲酰胺 |
1448188-57-5 |
詳細(xì)
|
cIAP1 Ligand-Linker Conjugates 5 |
|
2113688-20-1 |
詳細(xì)
|
N-Boc-O-tosylhydroxylamine |
N-BOC-O-對(duì)甲苯磺?;?羥胺 |
105838-14-0 |
詳細(xì)
|
Amino-PEG6-t-butyl ester |
氨基-五聚乙二醇-丙酸叔丁酯 |
1286281-32-0 |
詳細(xì)
|
Propargyl-PEG3-acid |
丙炔基-二聚乙二醇-羧酸 |
1347760-82-0 |
詳細(xì)
|
4-Amino-2-(1-methyl-2,6-dioxopiperidin-3-yl)isoindoline-1,3-dione |
N-甲基化的POMALIDOMIDE |
1352827-50-9 |
詳細(xì)
|
Pentafluorophenyl acetate |
乙酸五氟苯酯 |
19220-93-0 |
詳細(xì)
|
Propargyl-PEG6-acid |
丙炔基-五聚乙二醇-羧酸 |
1951438-84-8 |
詳細(xì)
|
Pomalidomide-PEG3-CO2H |
泊馬度胺-三聚乙二醇-酸 |
2138440-82-9 |
詳細(xì)
|
Pomalidomide-PEG2-CO2H |
泊馬度胺-二聚乙二醇-酸 |
2140807-17-4 |
詳細(xì)
|
Hydroxy-PEG6-t-butyl ester |
丙酸叔丁酯-六聚乙二醇 |
361189-64-2 |
詳細(xì)
|
BocNH-PEG6-acid |
叔丁氧羰基六聚乙二醇乙酸 |
391684-36-9 |
詳細(xì)
|
t-Boc-N-amido-PEG3-CH2CO2H |
5,8,11-三氧雜-2-氮雜十三烷二酸1-叔丁酯 |
462100-06-7 |
詳細(xì)
|
Hydroxy-PEG4-t-butyl ester |
丙酸叔丁酯-四聚乙二醇 |
518044-32-1 |
詳細(xì)
|
Propargyl-PEG1-acid |
丙炔-單乙二醇-羧酸 |
55683-37-9 |
詳細(xì)
|
Amino-PEG4-t-butyl ester |
15-氨基-4,7,10,13-四氧雜十五烷酸叔丁酯 |
581065-95-4 |
詳細(xì)
|
Bromo-PEG3-acid |
溴代-三聚乙二醇-羧酸 |
782475-35-8 |
詳細(xì)
|
N-(3,5-Bis(trifluoromethyl)phenyl)-2-chloroacetamide |
N1-[3,5-雙(三氟甲基)苯基]-2-氯乙酰胺 |
790-75-0 |
詳細(xì)
|
Isopropyl 1H-imidazole-1-carboxylate |
1H-咪唑-1-羧酸異丙酯 |
82998-18-3 |
詳細(xì)
|
Hydroxy-PEG5-t-butyl ester |
1-羥基-3,6,9,12,15-五氧雜十八烷-18-羧酸叔丁酯 |
850090-09-4 |
詳細(xì)
|
BocNH-PEG4-acid |
N-叔丁氧羰基-四聚乙二醇-乙酸 |
876345-13-0 |
詳細(xì)
|
VH032-thiol-C6-NH2 |
|
2098836-63-4 |
詳細(xì)
|
(S,R,S)-AHPC-propargyl |
(S,R,S)-AHPC-丙炔基 |
2098799-78-9 |
詳細(xì)
|
cIAP1 Ligand-Linker Conjugates 12 |
|
2095244-52-1 |
詳細(xì)
|
Lenalidomide-C5-NH2 |
3-[4-(5-氨基戊基)-1-氧代異吲哚啉-2-基]哌啶-2,6-二酮 |
2093388-45-3 |
詳細(xì)
|
cIAP1 Ligand-Linker Conjugates 14 |
|
1351169-40-8 |
詳細(xì)
|
cIAP1 Ligand-Linker Conjugates 2 |
|
1312302-14-9 |
詳細(xì)
|
cIAP1 Ligand-Linker Conjugates 11 |
|
1239943-19-1 |
詳細(xì)
|
cIAP1 Ligand-Linker Conjugates 15 |
|
1225433-96-4 |
詳細(xì)
|
E3 ligase Ligand 8 |
((2S,3R)-3-((((9H-芴-9-基)甲氧基)羰基)氨基)-2-羥基-4-苯基丁酰基)-L-亮氨酸 |
1225383-33-4 |
詳細(xì)
|
CC-885 |
1-(3-氯-4-甲基苯基)-3-((2-(2,6-二氧哌啶-3-基)-1-氧異吲哚-5-基)甲基)脲 |
1010100-07-8 |
詳細(xì)
|
Indisulam |
N-(3-氯-1H-吲哚-7-基)-1,4-苯二磺酰胺 |
165668-41-7 |
詳細(xì)
|
5-[[2-(2-aminoethoxy)ethyl]amino]-2-(2,6-dioxo-3-piperidinyl)-1H-Isoindole-1,3(2H)-dione, |
沙利度胺-5-氨基乙氧-乙胺 |
2412056-16-5 |
詳細(xì)
|
5-[(4-aminobutyl)amino]-2-(2,6-dioxo-3-piperidinyl)-1H-Isoindole-1,3(2H)-dione, |
|
2412056-39-2 |
詳細(xì)
|
Thalidomide-O-PEG4-azide |
薩力多胺-O-四聚乙二醇-疊氮 |
2380318-57-8 |
詳細(xì)
|
VH032-cyclopropane-F |
(2S,4R)-1-((S)-2-(1-氟環(huán)丙烷甲酰胺基)-3,3-二甲基丁?;?-4-羥基-N-(2-羥基-4-(4-甲基噻唑-5-基)芐基)吡咯烷-2-甲酰胺 |
2306193-99-5 |
詳細(xì)
|
E3 ligase Ligand 9 |
(S)-2-((2S,3R)-3-((叔丁氧羰基)氨基)-2-羥基-4-苯基丁酰氨基)-4-甲基戊酸 |
87304-15-2 |
詳細(xì)
|
Thalidomide |
沙利度胺 |
50-35-1 |
詳細(xì)
|
4-[2-(2,6-dioxo-3-piperidinyl)-2,3-dihydro-1,3-dioxo-1H-isoindol-5-yl]-1-Piperazinepropanoic acid, |
3-[4-[2-(2,6-二氧代-3-哌啶基)-1,3-二氧代-5-異吲哚啉基]-1-哌嗪基]丙酸 |
2591176-24-6 |
詳細(xì)
|
3(2H)-dione, 5-[4-[2-(2-aminoethoxy)ethyl]-1-piperazinyl]-2-(2,6-dioxo-3-piperidinyl)-1H-Isoindole-1, |
沙利度胺-哌嗪-一聚乙二醇-氨基 |
2357111-29-4 |
詳細(xì)
|
2-(2,6-dioxo-3-piperidinyl)-5-(1-piperazinyl)-1H-Isoindole-1,3(2H)-dione |
2-(2,6-二氧代哌啶-3-基)-5-(哌嗪-1-基)異吲哚啉-1,3-二酮 |
2154342-61-5 |
詳細(xì)
|
4-[4-(7-amino-1-oxopentyl)-1-piperazinyl]-2-(2,6-dioxo-3-piperidinyl)-1H-Isoindole-1,3(2H)-dione, |
|
2425605-15-6 |
詳細(xì)
|
4-[4-(6-amino-1-oxopentyl)-1-piperazinyl]-2-(2,6-dioxo-3-piperidinyl)-1H-Isoindole-1,3(2H)-dione, |
|
2425605-14-5 |
詳細(xì)
|
4-[4-(5-amino-1-oxopentyl)-1-piperazinyl]-2-(2,6-dioxo-3-piperidinyl)-1H-Isoindole-1,3(2H)-dione, |
|
2425605-13-4 |
詳細(xì)
|
Propargyl-PEG2-acid |
丙炔-單乙二醇-丙酸 |
1859379-85-3 |
詳細(xì)
|
Bromo-PEG2-acid |
溴基-乙二醇-乙酸 |
1807503-92-9 |
詳細(xì)
|
Amino-PEG5-t-butyl ester |
氨基-四聚乙二醇-丙酸叔丁酯 |
1446282-18-3 |
詳細(xì)
|
t-Boc-N-amido-PEG1-CH2CO2H |
5-叔丁氧羰基氨基-3-氧雜戊酸 |
142929-49-5 |
詳細(xì)
|
Bromo-PEG1-acid |
溴代-一聚乙二醇-羧酸 |
1393330-33-0 |
詳細(xì)
|
BocNH-PEG5-acid |
BOCNH-PEG5酸 |
890152-41-7 |
詳細(xì)
|
4-[7-(8-chloro-1-naphthalenyl)-5,6,7,8-tetrahydro-2-[(2S)-2-pyrrolidinylmethoxy]pyrido[3,4-d]pyrimidin-4-yl]-1-(2-fluoro-1-oxo-2-propen-1-yl)-, (2S)- |
2-PIPERAZINEACETONITRILE, 4-[7-(8-CHLORO-1-NAPHTHALENYL)-5,6,7,8-TETRAHYDRO-2-[(2S)- |
2326523-41-3 |
詳細(xì)
|
3-[3-[(2S)-2-[[[7-(8-chloro-1-naphthalenyl)-4-[(3S)-3-(cyanomethyl)-4-(2-fluoro-1-oxo-2-propen-1-yl)-1-piperazinyl]-5,6,7,8 |
3-[3-[(2S)-2-[[[7-(8-CHLORO-1-NAPHTHALENYL)-4-[(3S)-3-(CYANOMETHYL)-4-(2-FLUORO- |
2561529-98-2 |
詳細(xì)
|
4-[7-(8-chloro-1-naphthalenyl)-5,6,7,8-tetrahydro-2-[[(2S)-1-(4-pentyn-1-yl)-2-pyrrolidinyl]methoxy]pyrido[3,4-d]pyrimidin-4- |
4-[7-(8-CHLORO-1-NAPHTHALENYL)-5,6,7,8-TETRAHYDRO-2-[[(2S)-1-(4-PENTYN-1-YL)-2- |
2490716-96-4 |
詳細(xì)
|
LC-2 isomer |
LC-2異構(gòu)體 |
2502156-12-7 |
詳細(xì)
|